+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

From
From
From
From
Fibromyalgia - Pipeline Insight, 2024 - Product Thumbnail Image

Fibromyalgia - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
From
From
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 500 Pages +
  • Global
From
Human Papillomavirus (HPV) Vaccine Market Report 2025 - Product Thumbnail Image

Human Papillomavirus (HPV) Vaccine Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Epilepsy Therapeutics Market Report 2024-2034 - Product Thumbnail Image

Epilepsy Therapeutics Market Report 2024-2034

  • Report
  • February 2024
  • 213 Pages
  • Global
From
Loading Indicator